What DNA X, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 2 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 14,167 |
| Disposed | 0 | 0 |
| Net activity | +0 | +14,167 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Crolius Clayton | Chief Financial Officer | Feb 09 | Grant / award · A | +35,000 | — | — | 36,719 |
| Mulica Michael C | Acting CEO | Feb 09 | Grant / award · A | +50,000 | — | — | 54,071 |
| Lytton Laurence W | 10% owner | Jun 30 | Open-market sale · S | −400,514 | $1.39 | −$557K | 0 |
| Lytton Laurence W | 10% owner | Jun 26 | Open-market sale · S | −466,402 | $1.50 | −$700K | 400,514 |
| Steenstra Jack | Director | Apr 23 | Open-market sale · S | −23,381 | $1.45 | −$33.9K | 49,139 |
| Crolius Clayton | Chief Financial Officer | Apr 23 | Open-market sale · S | −11,634 | $1.45 | −$16.9K | 30,958 |
| Wang Jeffrey | Director | Apr 23 | Open-market sale · S | −4,478 | $1.45 | −$6.49K | 21,301 |
| Cassano James S | Director | Apr 23 | Open-market sale · S | −23,381 | $1.45 | −$33.9K | 49,126 |
| Becher Charles | See Remarks | Apr 23 | Open-market sale · S | −31,326 | $1.45 | −$45.4K | 62,668 |
| Mulica Michael C | Director | Apr 23 | Open-market sale · S | −27,818 | $1.45 | −$40.3K | 73,292 |
| Cassano James S | Director | Mar 31 | Grant / award · A | +46,728 | — | — | 72,507 |
| Steenstra Jack | Director | Mar 31 | Grant / award · A | +46,728 | — | — | 72,520 |
| Mulica Michael C | Director | Mar 31 | Grant / award · A | +46,728 | — | — | 101,110 |
| Liu Hao Peter | Chief Executive Officer | Feb 06 | Grant / award · A | +63,604 | — | — | 269,388 |
| Crolius Clayton | Chief Financial Officer | Feb 06 | Grant / award · A | +33,922 | — | — | 42,592 |
| Becher Charles | See Remarks | Feb 06 | Grant / award · A | +70,671 | — | — | 93,994 |
| Mulica Michael C | Director | Nov 13 | Open-market sale · S | −2,559 | $3.28 | −$8.39K | 54,382 |
| Mulica Michael C | Director | Nov 12 | Grant / award · A | +14,124 | — | — | 56,941 |
| Wang Jeffrey | Director | Jul 19 | Open-market sale · S | −1,623 | $3.67 | −$5.96K | 25,779 |
| Cassano James S | Director | Jul 19 | Open-market sale · S | −1,623 | $3.68 | −$5.97K | 25,779 |
Loading...